发明授权
US5534632A Macrocyclic carbamate immunomodulators 失效
大环氨基甲酸酯免疫调节剂

Macrocyclic carbamate immunomodulators
摘要:
Immunomodulatory macrocyclic compounds having the formula: ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein R.sup.8 and R.sup.9 are selected such that one of R.sup.8 and R.sup.9 is hydrogen, and the other is chosen from the group consisting of:(1) --OC(.dbd.NR.sup.10)-NHR.sup.10 ;(2) --OC(.dbd.O)-R.sup.11 ; and(3) --OC(.dbd.O)-NR.sup.12 R.sup.13 ;(4) --OC(.dbd.O)-N(OR.sup.14)R.sup.12 ;(5) --OC(.dbd.O)-NHNR.sup.12 R.sup.13 ;(6) --OC(.dbd.O)-NH-NHC(.dbd.O)-NR.sup.12 R.sup.13 ;(7) --OC(.dbd.O)-NH-NHS(O).sub.2 --NR.sup.12 R.sup.13 ; and(8) --OC(.dbd.O)-NH-NHC(.dbd.NR.sup.21 )-NR.sup.12 R.sup.13. as well as pharmaceutical compositions containing such compounds and methods for their use in immunosuppressive, antimicrobial, antifungal, antiviral, antiinflammatory and antiproliferative therapy.
公开/授权文献
信息查询
0/0